Renue Life Sciences, Inc.
PrivateLast Round
Seed
Oct 2, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Renue Life Sciences, Inc. operates in Healthcare & Life Sciences and is based in San Carlos, California. It was founded in 2026.
Renue Life Sciences, Inc. is a biotechnology company that develops AI-guided reprogramming therapeutics to address age-related and complex diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Renue Life Sciences, Inc. Comparables
Compare Renue Life Sciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gordian Biotechnology | 85% | |
| Shift Bioscience | 84% | |
| ReneuBio | 82% |
For institutional investors. Book with your work email.
Renue Life Sciences, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 2, 2026
$250K round completed.
For institutional investors. Book with your work email.
Renue Life Sciences, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Renue Life Sciences, Inc.'s valuation, stock price, and market status.
Is Renue Life Sciences, Inc. a public or private company?
Renue Life Sciences, Inc. is a private company.
What is the current stock price of Renue Life Sciences, Inc.?
Renue Life Sciences, Inc. is a private company, so its shares have no public market price. Caplight tracks Renue Life Sciences, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Renue Life Sciences, Inc. worth (valuation)?
Valuation information for Renue Life Sciences, Inc. is not publicly available.
Can I buy Renue Life Sciences, Inc. stock?
Renue Life Sciences, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Renue Life Sciences, Inc.'s last funding round?
Renue Life Sciences, Inc.'s most recent funding round was Seed on October 2, 2026.
Who are the main investors in Renue Life Sciences, Inc.?
Investor information for Renue Life Sciences, Inc. is not publicly disclosed.
Will Renue Life Sciences, Inc. IPO soon?
No public IPO plans have been announced for Renue Life Sciences, Inc..
How can I track Renue Life Sciences, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Renue Life Sciences, Inc.'s shares on secondary markets.